keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1].
説明 | FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1]. |
分子量 | N/A |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 50 mg/mL (48.59 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FTISADTSK acetate FTISADTSK Acetate Inhibitor inhibitor inhibit